Your coverage of Robert Gallo's annual lab meeting (F. Hoke, The Scientist, Nov. 14, 1994, page 1) revealed unmistakably that research based on the HIV theory of AIDS is at a standstill. Ten years after the discovery of what the newspapers call "HIV, the virus that causes AIDS," it is clear that scientists haven't a clue as to what HIV is supposed to be doing to the cells of the immune system. Gallo's own summary said that there are "conflicting views on the question of whether HIV kills T cell
After a decade of futility, HIV scientists are making no progress in explaining how a retrovirus can be killing cells it doesn't infect. How many more years will it take before biomedical science is willing to reconsider a theory that was established by a press conference, and that has generated nothing since but a steady stream of failed predictions?
Phillip E. Johnson
Professor of Law
University of California
Berkeley, Calif. 94720-2499
E-mail: philjohn@garnet.berkeley.edu
Add The Scientist as a preferred Google source to see more of our trusted coverage.
When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.
View this Issue
Explore strategies for improving recombinant adeno-associated virus production in transient HEK293 suspension cultures while maintaining vector quality and supporting scalable viral vector manufacturing.
Discover how tissue-resident memory T cells develop within the respiratory tract and how these findings are advancing respiratory virus immunity, vaccine research, and high-throughput immune profiling.
Bench architecture, primer design, and liquid handling set an assay's limit as throughput climbs.
Explore emerging mechanisms of immune checkpoint inhibitor resistance in hepatocellular carcinoma (HCC) and how combination immunotherapy strategies may improve antitumor immune responses and patient-specific treatment approaches.
European customers can now subscribe to Sino Biological’s newsletter to receive a special gift and unlock access to EliteScience benefits.
Sino Biological’s trial program enables qualified customers to evaluate SuperNuclease Pro in their specific bioprocessing applications, facilitating faster technology assessment and informed decision-making during process development
This release expands on Sino Biological's comprehensive Tau protein product portfolio, designed to accelerate neurodegenerative disease research.
Resipher measures cellular respiration (OCR) continuously in standard 96-well plates inside your incubator, for days to weeks. No media swaps, dyes, or transfers. A live-cell functional readout for drug safety, metabolism, and mitochondrial health.
